← Back to Search

Behavioural Intervention

Brain-Spinal Cord-Muscle Response Training for Spinal Cord Injury

N/A
Recruiting
Led By Aiko K Thompson, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Signs of weak ankle dorsiflexion at least unilaterally
Neurologically stable (>1 year post SCI)
Must not have
Motoneuron injury
Medically unstable condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through 3 months post intervention

Summary

This trial is testing whether a brain-spinal cord-muscle response training program can improve movement control in people who have had a spinal cord injury.

Who is the study for?
This trial is for individuals with spinal cord injury who can move at least 10 meters with or without help, have weak ankle movement, and are stable on their current medications. They should be over a year post-injury and neurologically stable. People with severe heart conditions, cognitive impairments, seizures, metal head implants, no muscle response in tests, daily leg stimulation therapy or pregnancy cannot participate.
What is being tested?
The study examines how brain-spinal cord-muscle response training can improve control of movements after a spinal cord injury. Participants will undergo sessions involving standing, sitting and walking while being monitored through electrodes on the legs and non-painful transcranial magnetic stimulation over the head.
What are the potential side effects?
While there's little to no discomfort expected from the transcranial magnetic stimulation used to examine brain-to-muscle connections during this study; however individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have weakness in lifting my foot or toes upward on at least one side.
Select...
My spinal cord injury has been stable for over a year.
Select...
I can walk at least 10 meters with or without help, but not using parallel bars.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a motor neuron injury.
Select...
I have a condition that makes my health unstable.
Select...
I have a history of epileptic seizures.
Select...
I have metal implants in my head.
Select...
I am not pregnant.
Select...
I have difficulty with memory or thinking clearly.
Select...
I have a known heart condition.
Select...
I use electrical stimulation on my leg every day.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through 3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 3 months post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in excitability of the excitability of the brain as measured by Short Interval Intra-cortical Inhibition (SICI)
Change in excitability/strength of the spinal cord-muscle pathway as measured by Change in F-wave amplitude (mV) and F-wave occurrence (out of 30 trials) in response to nerve stimulation--Studied Leg
H-Reflex
+6 more
Secondary study objectives
Body Weight Changes
Change in excitability/strength of the spinal cord-muscle pathway as measured by Change in F-wave amplitude (mV) and F-wave occurrence (out of 30 trials) in response to nerve stimulation--Contralateral Leg
Change in hip joint motion during walking (deg)--Both Legs
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Up-conditioning (UC) GroupExperimental Treatment1 Intervention
Group II: Control (NC) GroupPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Operant Conditioning
2022
N/A
~30

Find a Location

Who is running the clinical trial?

National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,385 Previous Clinical Trials
652,644 Total Patients Enrolled
13 Trials studying Paralysis
600 Patients Enrolled for Paralysis
Medical University of South CarolinaLead Sponsor
979 Previous Clinical Trials
7,400,921 Total Patients Enrolled
2 Trials studying Paralysis
41 Patients Enrolled for Paralysis
Aiko K Thompson, PhDPrincipal InvestigatorMedical University of South Carolina
1 Previous Clinical Trials
32 Total Patients Enrolled

Media Library

Paralysis Research Study Groups: Up-conditioning (UC) Group, Control (NC) Group
~8 spots leftby Nov 2025